www.fgks.org   »   [go: up one dir, main page]

Potential population impact of changes in heroin treatment and smoking prevalence rates: using Population Impact Measures

Eur J Public Health. 2009 Jan;19(1):28-31. doi: 10.1093/eurpub/ckn103. Epub 2008 Nov 11.

Abstract

Background: The drug misuse and asthma are major health problems in urban settings. There are effective interventions to reduce cigarette smoking and also to treat heroin use; in the context of European System of Urban Health Indicators Project (EURO-URHIS), we explored the use of Population Impact Measures (PIMs) to describe the potential for increase in methadone use and reduction in cigarette smoking to reduce deaths -from heroin use- and asthma events in examples of urban populations.

Methods: The two PIMs calculated here are the Number of Events Prevented in your Population (NEPP) and the Population Impact Number of Eliminating (or reducing the prevalence of) a Risk Factor (PIN-ER-t).

Results: Increasing methadone treatment uptake from its current levels to 90% would prevent 21 (95% CI: 11-34) deaths in Manchester City, 218 (95% CI: 114-339) in Greater London and overall 1 243 (95% CI: 641-1953) in England in 1 year. In males 2 (95% CI: -22 to 28), 27 (95% CI: -296 to 363) and 170 (95% CI: -1757 to 2186) and in females 36 (95% CI: 6-70), 0 and 2312 (95% CI: 934-3783) fewer asthma cases per year would have been expected in Manchester City, Greater London and overall in England respectively, if the smoking prevalence is reduced from current levels to 20% in both sexes.

Conclusions: PIMs provide estimates of absolute risk and benefit to a total population, of potential use to policy-makers since current practice and intervention goals are taken into account.

MeSH terms

  • Adolescent
  • Adult
  • Asthma / epidemiology
  • England / epidemiology
  • Female
  • Health Status Indicators
  • Heroin Dependence / drug therapy*
  • Heroin Dependence / mortality
  • Humans
  • Male
  • Methadone / administration & dosage
  • Methadone / therapeutic use
  • Middle Aged
  • Population Surveillance
  • Risk Factors
  • Smoking / epidemiology*
  • Young Adult

Substances

  • Methadone